July 24, 2025 AlzeCure’s rights issue oversubscribed and the company resolves on a directed share issue under the framework of an overallotment option
July 16, 2025 AlzeCure Receives Additional Subscription Commitments of Approximately SEK 7 million in the ongoing Rights Issue
July 2, 2025 The extraordinary general meeting of AlzeCure Pharma AB approved the decision on the new issue of shares
June 17, 2025 AlzeCure Receives an Additional Subscription Commitment of Approximately SEK 5 million in the upcoming Rights Issue
